insights_auto
Prospek: 52.0% bullish·16.0% bearish
Buka analisischevron_right
SYK:NYSE
Stryker Corp
US$296,00
arrow_upward
+0,94%(+2,77) 1 HR
16 Okt, 10.38.18 GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk SYK...
Pembukaan
US$295,89
Tinggi
US$299,67
Rendah
US$294,90
Kapitalisasi pasar
113,54 M
Volume rata-rata
2,93 jt
Volume
440,06 rb
Dividen
1,19%
Dividen per kuartal
US$0,88
Tanggal tanpa dividen
30 Sep 2026
Rasio P/E
30,67
Harga tinggi dalam 52 minggu terakhir
US$392,55
Harga rendah dalam 52 minggu terakhir
US$267,00
EPS
US$9,65
Beta
0,77
Saham beredar
383,57 jt
Jumlah karyawan
56 rb
Pembukaan
US$295,89
Tinggi
US$299,67
Rendah
US$294,90
Kapitalisasi pasar
113,54 M
Volume rata-rata
2,93 jt
Volume
440,06 rb
Dividen
1,19%
Dividen per kuartal
US$0,88
Tanggal tanpa dividen
30 Sep 2026
Rasio P/E
30,67
Harga tinggi dalam 52 minggu terakhir
US$392,55
Harga rendah dalam 52 minggu terakhir
US$267,00
EPS
US$9,65
Beta
0,77
Saham beredar
383,57 jt
Jumlah karyawan
56 rb
Artikel berita
Dari sumber web dan partner berita
Zacks
·
2 jam yang lalu
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?
GuruFocus
·
17 jam yang lalu
Is It Too Late to Buy Stryker Corp (SYK) After 4.1% Rally? GF Va
Simply Wall Street
·
17 jam yang lalu
Stryker (SYK) Wins FDA Clearance, Is The 9% Undervaluation Enough?
News Corp
·
18 jam yang lalu
Stryker Corp. stock outperforms competitors on strong trading day
Profil
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
Tentang Stryker Corp
CEOKevin A. Lobo
Karyawan56 rb
Didirikan1941
Kantor PusatKalamazoo, Michigan, Amerika Serikat
Sektor-
Situsstryker.com